Conventional MRI radiomics in patients with suspected early- or pseudo-progression

BACKGROUND: After radiochemotherapy, 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic value of radiomics in patients with suspected EP or Psp. METHODS: Radiomics features (RF) of 76...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Bani-Sadr, Alexandre, Eker, Omer Faruk, Berner, Lise-Prune, Ameli, Roxana, Hermier, Marc, Barritault, Marc, Meyronet, David, Guyotat, Jacques, Jouanneau, Emmanuel, Honnorat, Jerome, Ducray, François, Berthezene, Yves
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7212855/
https://ncbi.nlm.nih.gov/pubmed/32642655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados